Biotricity Past Earnings Performance

Past criteria checks 0/6

Biotricity's earnings have been declining at an average annual rate of -14.1%, while the Healthcare Services industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 45.8% per year.

Key information


Earnings growth rate


EPS growth rate

Healthcare Services Industry Growth1.7%
Revenue growth rate45.8%
Return on equityn/a
Net Margin-123.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding

Jan 26
Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding

Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)

Oct 26
Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)

Biotricity GAAP EPS of -$0.09, revenue of $2.06M

Aug 15

Biotricity, Inc.: A First Take

Jul 28

Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?

Apr 09
Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?

Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?

Dec 11
Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?

Biotricity: Capital Raise Leads To Buying Opportunity

Aug 31

Revenue & Expenses Breakdown

How Biotricity makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqCM:BTCY Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2412-15153
31 Dec 2312-15143
30 Sep 2311-17163
30 Jun 2311-18173
31 Mar 2310-20183
31 Dec 229-21193
30 Sep 229-23193
30 Jun 228-29203
31 Mar 228-30193
31 Dec 217-30163
30 Sep 216-27152
30 Jun 215-19122
31 Mar 213-16122
31 Dec 203-16132
30 Sep 202-14122
30 Jun 202-13112
31 Mar 201-11101
31 Dec 191-881
30 Sep 191-871
30 Jun 191-871
31 Mar 190-971
31 Dec 180-1082
30 Sep 180-982
30 Jun 180-972
31 Mar 180-962
31 Dec 170-851
30 Sep 170-851
30 Jun 170-951
31 Mar 170-851
31 Dec 160-741
30 Sep 160-631
30 Jun 160-531
31 Mar 160-531
31 Dec 150-541
30 Sep 150-431

Quality Earnings: BTCY is currently unprofitable.

Growing Profit Margin: BTCY is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BTCY is unprofitable, and losses have increased over the past 5 years at a rate of 14.1% per year.

Accelerating Growth: Unable to compare BTCY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BTCY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (7.1%).

Return on Equity

High ROE: BTCY's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.